This post was originally published on this site
Although improving travel demand amid widespread COVID-19 vaccinations has helped JBLU gain 46.2% over the past year, the stock is down 13.6% over the past month. In addition, the stock is trading 32.7% below its 52-week high of $21.96, which it hit on June 4. Also, JBLU is currently trading lower than its 50-day and 200-day moving averages of $17.21 and $16.91, respectively, which indicates a downtrend.
While its long-term strategic partnerships and expanded presence in New York should bode well for the stock, its continuing unit cost pressures from fuel prices and a slower-than-expected recovery could be concerning.
